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Abstract
Objective
Short-term variability of the QT-interval (STV-QT) was shown to be associated with an
increased risk of ventricular arrhythmias. We aimed at investigating (a) whether STV-QT
exhibits circadian pattern, and (b) whether such pattern differs between patients with high
and low arrhythmia risk.
Methods
As part of the ongoing EU-CERT-ICD study, 24h high resolution digital ambulatory 12-lead
Holter recordings are collected prior to ICD implantation for primary prophylactic indication.
Presently available patients were categorized based on their arrhythmia score (AS), a cus-
tom-made weighted score of the number of arrhythmic events on the recording. STV-QT
was calculated every hour in 30 patients of which 15 and 15 patients had a high and a low
AS, respectively.
Results
The overall dynamicity of STV-QT showed high intra- and inter-individual variability with dif-
ferent circadian patterns associated with low and high AS. High AS patients showed a prom-
inent peak both at 08:00 and 18:00. At these times, STV-QT was significantly higher in the
high AS patients compared to the low AS patients (1.22ms±0.55ms vs 0.60ms±0.24ms at
08:00 and 1.12ms±0.39ms vs 0.64ms±0.29ms at 18:00, both p < 0.01).
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Conclusion
In patients with high AS, STV-QT peaks in the early morning and late afternoon. This poten-
tially reflects increased arrhythmia risk at these times. Prospective STV-QT determination
at these times might thus be more sensitive to identify patients at high risk of ventricular
arrhythmias.
Introduction
Sudden cardiac death (SCD) due to ventricular arrhythmias remains an important health
problem, accounting for approximately 60% of total cardiovascular mortality.[1] Prophylactic
implantation of implantable cardioverter-defibrillators (ICD) was shown to reduce mortality
in patients with a reduced left ventricular ejection fraction (LVEF).[2,3] LVEF reduction is
presently used in international guidelines as a class I indication for ICD implantation in
patients with left ventricular dysfunction.[4] However, LVEF lacks sensitivity and specificity of
patients stratification, since a large proportion of patients suffering from sudden cardiac arrest
have LVEF above the 35% cut-off.[5] Furthermore, in recent registries of ICD recipients, the
incidence of appropriate shock [6,7] was found substantially lower than that reported in the
original MADIT II and SCD-HeFT trials,[2,3] possibly explained by improved pharmacologi-
cal heart failure treatment and ICD-programming algorithms. Consequently, up to two thirds
of ICD recipients will never receive an appropriate ICD shock during their lives,[8] indicating
that more accurate characterization of a patient at high SCD risk is urgently needed. In the
search for better risk assessment, ECG-derived risk parameters are continuously investigated
since the ECG is an inexpensive, easy to use, and widely accessible non-invasive tool.
Short-term variability of the QT-interval (STV-QT) is a relatively new ECG-based parame-
ter that captures the repolarization instability in 30 consecutive beats.[9] An increased STV-
QT was shown in patients with drug-induced and congenital long QT-syndrome and in
patients with non-ischemic heart failure with a history of ventricular arrhythmias.[10–12]
Presently, the predictive value of STV-QT is further evaluated in the primary prevention ICD-
population as part of the EUropean Comparative Effectiveness Research to assess the use of
primary prophylacTic Implantable Cardioverter Defibrillators (EU-CERT-ICD) study. In con-
trast to previous studies in which STV-QT was measured in 2-minute 12-lead ECG recordings,
the EU-CERT-ICD study uses high resolution 24-hour Holter recordings for STV-QT analysis.
The use of long-term recordings leads to the question of when to take a 30-beat sample during
the 24 hours of the recording.
Yet, little is known about the STV-QT changes during the day and/or whether the circadian
pattern of STV-QT is different in patients at low and high SCD risk. If such a difference exists,
calculation of STV-QT at a certain time of the day might increase the sensitivity and specificity
of this parameter in identifying the patients at risk. Therefore, as a methodological pilot study
of EU-CERT-ICD, we aimed at investigating (a) whether STV-QT exhibits a circadian pattern
and (b) whether this pattern differs between high and low risk patients.
Materials & methods
Study design
The EU-CERT-ICD study is a currently enrolling prospective, multicenter, observational
study (NCT 02064192) that aims to assess electrocardiographic parameters for prediction of
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all-cause mortality and appropriate ICD-shocks. The study plans to recruit 2500 patients with
ischemic and non-ischemic cardiomyopathy fulfilling the international treatment guidelines
criteria for primary prophylactic ICD implantation.[13] Patients who are candidate for cardiac
resynchronization therapy (CRT) or secondary prophylactic ICD are excluded. The protocol
was approved by the institutional review board or ethics committee at each participating hos-
pital and was in compliance with the Declaration of Helsinki. All patients provided written
informed consent.
Clinical characteristics including age, sex, race, NYHA class, comorbidities and cardiovas-
cular drug treatment are collected at baseline. Prior to ICD implantation, all patients also
undergo a 24-hour 12-lead digital Holter recording using the SEER 12 recorder programmed
at 1024 Hz sampling frequency (Getemed, Teltow, Germany). In addition to STV-QT, other
ECG-derived parameters, including microvolt T-wave alternans, heart rate variability, heart
rate turbulence, and T-wave morphology will be prospectively assessed for the risk stratifica-
tion purposes. In the current methodological pilot study, STV-QT of 30 cardiac cycles was
determined at the beginning of every hour during the 24h recording in a subpopulation of
already enrolled patients.
Measurement of STV-QT
STV-QT was determined in lead V2 and was calculated using the method of fiducial segment
averaging (FSA).[14] First, each QRS-complex was aligned around a trigger point (usually the
the R-peak) by cross correlating each individual complex with the average of the other com-
plexes and then shifted until maximal correlation is achieved. Next, the different fiducial
points, i.e. the QRS-onset and the end of T-wave, were aligned separately by the same tech-
nique using a segment of 30 samples around the fiducial point. Correct alignment was checked
visually by one of the authors (D.S.) and manually adjusted where necessary. The advantage of
our custom-made software is that the program preserves the amount of shifting for each indi-
vidual beat and thus the QT-interval of each beat can be derived from the individual fiducial
point estimates.
Using Poincare´ plots, the QT-interval of each complex was plotted against the former.
STV-QT was defined (as proposed by Thomson et al. [15]) as the mean orthogonal distance of
the points to the line of identity, calculated by the formula
P
jDnþ1   Dnj=N 
ffiffiffi
2
p
, where D
represents the QT-interval and N is the number of beats (30 in this case). Ventricular and atrial
premature complexes together with the following post-extrasystolic beat were excluded from
the analysis. In addition to STV-QT, both the RR-interval and QT-interval of the 30 beats were
measured automatically.
Endpoints
No definite endpoints, e.g. all-cause mortality or appropriate ICD shocks, are presently
known. Nevertheless, previous studies have shown that the presence of non-sustained ventric-
ular tachycardia (nsVT) and/or a high frequency of premature ventricular complexes (PVC)
are independent predictors of SCD and/or appropriate ICD shocks.[16,17] Therefore, to dif-
ferentiate between high and low risk patients, the number of arrhythmic events on the Holter
recording was used as a surrogate endpoint. A custom-made arrhythmia score (AS) was
designed for this purpose and described in Table 1. Arbitrarily and solely for the purposes of
this methodological pilot study, patients were classified based on their AS into three groups:
low AS (< 100 points/24h), moderate AS (between 100 and 1000 points/24h) and high AS
(>1000 points/24h). Only low AS and high AS patients were included in the present methodo-
logical study in order to differentiate clearly between low and high arrhythmia risk.
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Statistical analysis
Data are expressed as mean ± standard error of the mean (SEM). Repeated ANOVA with Bon-
ferroni correction for multiple comparisons was used for within group analysis. Between-
group analysis was performed using two-tailed Student t-test assuming different variances.
Pearson’s correlation coefficients were used for correlation analyses. Calculations were per-
formed using SPSS (version 23, IBM). P-values 0.05 were considered significant.
Results
Out of the EU-CERT-ICD Holter database, AS was assessed for already enrolled patients.
Patients with atrial fibrillation, less then 23 hours of noise-free recording or flat T-waves in the
precordial leads were excluded. A total of 30 patients were selected based on their AS, of which
15 and 15 patients had a high and low AS, respectively.
Baseline criteria
Table 2 shows baseline characteristics of the patients included in the analysis. The mean age
was 60 ± 2 years and 80% were men. Patients with high AS appeared to be slightly but not sig-
nificantly older compared to the low AS patients (p = 0.06). A slight majority of patients had
ischemic cardiomyopathy (53%) with a mean left ventricular ejection fraction of 27% ± 1%.
Significantly more patients in the high AS group had hypertension. The use of heart failure
medications was not different between the two groups.
Diurnal pattern of RR and QT
The circadian profile of RR- and QT-intervals is shown in Fig 1. As expected, both show higher
values at night with a peak at around 04:00, a clear drop in the morning and significantly lower
values during the day. No significant differences were found in RR-interval between the low
AS and high AS group (Fig 1B). The QT-interval of the high AS appeared to be slightly but not
significantly longer than that of the low AS group during the day.
Diurnal pattern of STV-QT
No clear circadian pattern of STV-QT was found in the total cohort. Nevertheless, two small
non-significant peaks are visible at 08:00 and 18:00 (Fig 2). A high intra- and inter-individual
variability of STV-QT was seen, mainly in the high AS group (Fig 3). A different hour-by-hour
behaviour of STV-QT was seen in the low AS-group and high AS-group (Fig 4). While the low
AS patients showed a more-or-less stable STV-QT during the day with low variability, high AS
patients showed significant STV-QT peaks (p< 0.05) at 08:00 and 18:00. At these time points,
Table 1. Arrhythmia score (AS).
Arrhythmic event points
Single PVC 1
Couplet 2
Triplet 3
Bigeminy 4
Non-sustained VT (> 3 complexes) 5
AS is defined as the sum of the points per 24 hours
https://doi.org/10.1371/journal.pone.0183199.t001
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STV-QT was significantly higher in high AS patients compared to low AS patients (1.22ms
±0.55ms vs 0.60ms±0.24ms at 08:00 and 1.12ms±0.39ms vs 0.64ms±0.29ms at 18:00, both
p< 0.01). At other time points, 07:00, 12:00 and 16:00, STV-QT was also increased in the high
AS group, but the differences were less expressed. At several time points, especially during the
night, STV-QT did not differ between the low and high AS groups.
Discussion
The presented results show (a) STV-QT intra- and interindividual variability, and (b) distinct
STV-QT peaks in the early morning and late afternoon that are not seen in the low AS patients.
Interestingly, at both of these time points the QT interval was the shortest. In previous animal
studies, a positive relation was found between STV and action potential durations (APD) with
higher STV at longer APD.[18] This can be explained by the absolute increase in APD varia-
tion at longer APD and does not reflect higher repolarization instability. Nevertheless, the
opposite was found in the high AS patients in the current study: the highest STV-QT was seen
when QT-interval was the shortest. This implies that an independent proarrhythmic compo-
nent might be partly responsible for this STV-QT increase.
In previous STV-QT clinical studies, a 2-minute ECG was taken at arbitrary during day-
time hours. Nevertheless, as we have shown, the discriminative power of STV-QT varies sub-
stantially between 8.00 and 17:00. For instance, in the data of this patient sub-population, sam-
ples taken around 14:00 or 15:00 would be less useful for the distinction between the low and
high AS groups. It seems plausible to propose that sampling at the time points of 8:00 or 18:00
might increase the predictive capabilities of STV-QT.
Table 2. Baseline characteristics of study cohort (n = 30).
Mean ± SEM or N (%) low AS (n = 15) high AS (n = 15) Total (n = 30)
Age, years 55.8 ± 3.4 64.3 ± 2.4 60.1 ± 2.2
Sex
Female 3 (20%) 2 (13.3%) 5 (17%)
Male 12 (80%) 13 (86.7%) 25 (83)
Leading cardiac disease
DCM 7 (46.7%) 6 (40%) 13 (43%)
ICM 8 (53.3%) 9 (60%) 17 (57%)
LVEF, percentage 26.8 ± 1.7 27.0 ± 1.7 26.9 ± 1.2
NYHA
I or II 11 (73%) 9 (60%) 20 (67%)
III 4 (27%) 6 (40%) 10 (33%)
Smoking 11 (73.7%) 10 (66.7%) 21 (70%)
Diabetes mellitus 5 (33.3%) 7 (46.7%) 12 (40%)
hypertension 4 (26.7%) 13 (86.7%)* 17 (57%)
Beta-blocker 14 (93.3%) 14 (93.3%) 28 (93%)
ACEi/ARB 15 (100%) 13 (86.7%) 28 (93%)
MRA 12 (80%) 15 (100%) 27 (90%)
statin 12 (80%) 11 (73.3%) 23 (77%)
Class I or III antiarrhythmic drugs 1 (6.7%) 2 (13.3%) 3 (10%)
* p < 0.05 high AS vs low AS. AS = arrhythmia score; DCM = dilated cardiomyopathy; ICM = ischemic cardiomyopathy; NYHA = New York Heart
Association; ACEi = ACE-inhibitor; ARB = angiotensin II receptor blocker; MRA = mineralocorticoid receptor antagonist.
https://doi.org/10.1371/journal.pone.0183199.t002
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Fig 1. Circadian pattern of RR- and QT-interval. (A) mean ± SEM at beginning of every hour of total cohort (n = 30). Significant higher values are
seen at night compared to during the day. * = p< 0.05 compared to 0:00. (B) Mean ± SEM at beginning of every hour of low AS-group (blue line,
n = 15) and high AS group (red line, n = 15). No significant differences are found in the circadian pattern of RR-interval or QT-interval between low
and high AS group.
https://doi.org/10.1371/journal.pone.0183199.g001
Fig 2. Circadian pattern of STV-QT. Mean ± SEM at beginning of every hour of total cohort (n = 30). No
clear circadian pattern is found, however, two non-significant peaks at 08:00 and 18:00 can be discerned.
https://doi.org/10.1371/journal.pone.0183199.g002
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STV-QT as a marker of arrhythmic risk
Finding a highly sensitive and specific ECG-derived parameter predictive for sudden cardiac
death remains the holy grail in the field of electrocardiology. In particular, a risk stratification
technique is urgently needed that identifies arrhythmic rather than overall mortality risk. The
most promising ECG-based risk parameters, such as microvolt T-wave alternans [19] or QT-
variability index (QTVI)[20] are markers of abnormal repolarization and reflect the electrical
substrate that predisposes to ventricular arrhythmias. However, none of these parameters have
yet been incorporated into clinical practice. STV-QT has the advantage to reflect instability of
repolarization on a consecutive basis and can be measured on 30 complexes instead of 256
complexes that are required to calculate QTVI. The method of fiducial segment averaging
eliminates the problem of identification of the end of the T-wave of every complex separately,
therefore diminishes measurement error.[14] STV-QT has been investigated in a number of
Fig 3. Circadian pattern of STV-QT in individual patients. Individual patients in low AS group (left) and high AS group (right). High inter- and
intraindividual variability can be seen, which is more pronounced in the high AS group.
https://doi.org/10.1371/journal.pone.0183199.g003
Fig 4. Circadian pattern of STV-QT in AS subgroups. Mean ± SEM at beginning of every hour in low AS (blue line,
n = 15) and patients with high AS (red line, n = 15). * p < 0.05 compared to 0:00; § p <0.05 compared to low AS. STV-QT
peaks at 08:00 and 18:00 in high AS patients, but is stable during the day in low AS patients.
https://doi.org/10.1371/journal.pone.0183199.g004
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retrospective studies with a wide variety of populations that are at risk of SCD and shows
potential for arrhythmic risk prediction. As part of the EU-CERT-ICD study this parameter
will be evaluated prospectively in a large cohort of primary prophylactic ICD patients to fur-
ther establish its role in risk stratification.
Circadian pattern of STV-QT resembles circadian profile of sudden
cardiac death
Interestingly, the distinct peaks of STV-QT in the early morning and late afternoon in the high
AS patients resemble the circadian distribution of sudden cardiac death found in large popula-
tion-based studies.[21,22] These large studies found a peak between 6:00 and noon and a sec-
ondary lower peak between 17:00 and 18:00. The same diurnal distribution was found in
studies investigating the circadian variation of appropriate ICD-shocks.[23,24] The increased
incidence of SCD in the morning may be linked to arousal-related increase of the sympathetic
tone, which might increases the myocardial electrical instability and decreases the threshold
for ventricular fibrillation. In experimental studies, left stellate ganglion nerve activity
(SGNA), which reflects discharge of the sympathetic nervous system, was reported to show
similar circadian profile with a high peak in the early morning in dogs with pacing induced
heart failure or experimentally induced myocardial infarction.[25–27] SGNA increase was also
shown to precede the occurrence of ventricular arrhythmia.[28]
QT variability and the autonomous nervous system
A relation between autonomic tone and higher beat-to-beat QT variability has previously been
reported. Yeragani et al investigated the effect of posture and isoproterenol infusion on QT
variability and described significantly higher QT variability in standing position and after the
infusion of isoproterenol.[29] Recently, a significant correlation was shown between elevated
STV-QT and parameters of sympathetic predominance in patients with impaired glucose tol-
erance.[30] A study by Piccirillo et al. found a positive relation between the level of anxiety and
a high QTVI.[31] On the other hand, QT variability was significantly reduced after administra-
tion of metoprolol or carvedilol compared to placebo in patients with ischemic cardiomyopa-
thy.[32] Also, in a SGNA activity study, the dogs with high sympathetic activity showed
significantly higher QT variability index compared to dogs with low sympathetic activity.[33]
Noteworthy, this difference was only seen in the dogs with pacing-induced heart failure.
Although all these studies used other QT-variability expressions, it seems reasonable to expect
the same differences for STV-QT.
The increased beat-to-beat repolarization variability during high adrenergic drive might be
caused by the autonomous nervous system effects during reduced repolarization reserve. In
cellular experiments under baseline conditions, selective IKs blockade does neither increase
repolarization variability nor results in arrhythmias because of compensatory effects of other
repolarizing currents[34]. However, when β-adrenergic stimulation is added to IKs blockade,
repolarization variability increases significantly and early and delayed afterdepolarizations
start to occur.
In our study population, i.e. patients with left ventricular dysfunction, a reduced repolariza-
tion reserve is likely because of repolarizing currents downregulation.[35] Sympathetic activity
during arousal might thus exhaust the repolarization reserve explaining the STV-QT rise. The
reasons for the second peak in the late afternoon are more speculative. Its might be related to
periprandial changes in the autonomic modulations.
Circadian pattern of STV-QT
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Limitations
The present study has important limitations. First, because of nature of a methodological pilot
study, the sample size is small. Second, we used a custom-made score of the number of
arrhythmic events on the Holter recording to categorize patients into high and low arrhythmic
risk. Whilst this might reasonably correspond to some previous publications, we have no data
on actual arrhythmic risk in these patients. A recent study by Seegers et al[16] found a high
number of premature ventricular complexes predicting appropriate ICD shocks but not all-
cause mortality. Nevertheless, in a substudy of the Prospective Randomized Milrinone Survival
Evaluation (PROMISE) trial, high burden of ventricular ectopy on Holter recordings predicted
SCD.[17] Finally, no continuous measurement of STV-QT during the 24 hours was per-
formed. The current method of FSA is semi-automatically which requires manual identifica-
tion of fiducial points. Currently, a fully automatic version is being developed and the first
results show accurate STV-QT measurements in simulated data.[36]
Conclusions
STV-QT shows high intra- and inter-individual 24-hour variability with peaks in the early
morning and late afternoon in high AS patients. Studies on the circadian variation of SCD
show a similar circadian profile. Determination of STV-QT at these time point might be more
sensitive in identifying the patient at risk. It is therefore plausible to propose that the evalua-
tion of the predictive power of STV-QT in the EU-CERT-ICD study concentrates primarily
on these time points.
Supporting information
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